Revenue for the period increased 2% y-o-y to RM4.37 billion on continued growth in key markets and a return of both local and foreign patients. The ramp up of Gleneagles Hong Kong Hospital and contribution from General Hospital Acibadem Bel Medic acquired in July 2021 also played a part, partially offset by the expected tapering of Covid-19 related services.
IHH Healthcare has reported earnings of RM612 million ($190 million), up 27% y-o-y for its 2QFY2022 ended June 30.
This translates to basic earnings per share (EPS) of 6.69 sen for the quarter, compared to EPS of 5.26 sen a year ago.
